113 related articles for article (PubMed ID: 7659101)
1. Dd is the only gene that controls NK cell resistance of heterozygous H-2b/d cells.
Zheng WP; Kiura K; Nakamura I
Mol Immunol; 1995 Jul; 32(10):773-6. PubMed ID: 7659101
[No Abstract] [Full Text] [Related]
2. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ
Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex genes determine natural killer cell tolerance.
Dorfman JR; Raulet DH
Eur J Immunol; 1996 Jan; 26(1):151-5. PubMed ID: 8566058
[TBL] [Abstract][Full Text] [Related]
4. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
Murphy WJ; Kumar V; Bennett M
J Exp Med; 1987 Nov; 166(5):1499-509. PubMed ID: 3316472
[TBL] [Abstract][Full Text] [Related]
5. Impaired MHC class I (H-2Dd)-mediated protection against Ly-49A+ NK cells after amino acid substitutions in the antigen binding cleft.
Waldenström M; Sundbäck J; Olsson-Alheim MY; Achour A; Kärre K
Eur J Immunol; 1998 Sep; 28(9):2872-81. PubMed ID: 9754574
[TBL] [Abstract][Full Text] [Related]
6. The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld.
Milisauskas VK; Nakamura I
Eur J Immunol; 1994 Feb; 24(2):336-42. PubMed ID: 8299682
[TBL] [Abstract][Full Text] [Related]
7. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
[TBL] [Abstract][Full Text] [Related]
8. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.
Höglund P; Ljunggren HG; Ohlén C; Ahrlund-Richter L; Scangos G; Bieberich C; Jay G; Klein G; Kärre K
J Exp Med; 1988 Oct; 168(4):1469-74. PubMed ID: 3171481
[TBL] [Abstract][Full Text] [Related]
9. Effects of altered antigen processing on H-2Dk mediated NK inhibition in a murine T lymphoma model.
Van Ginderachter J; Raes G; Devoogdt N; De Baetselier F; Geldhof A
Adv Exp Med Biol; 1998; 451():237-40. PubMed ID: 10026878
[No Abstract] [Full Text] [Related]
10. Mapping the ligand of the NK inhibitory receptor Ly49A on living cells.
Chung DH; Natarajan K; Boyd LF; Tormo J; Mariuzza RA; Yokoyama WM; Margulies DH
J Immunol; 2000 Dec; 165(12):6922-32. PubMed ID: 11120818
[TBL] [Abstract][Full Text] [Related]
11. Cre recombinase-mediated inactivation of H-2Dd transgene expression: evidence for partial missing self-recognition by Ly49A NK cells.
Ioannidis V; Zimmer J; Beermann F; Held W
J Immunol; 2001 Dec; 167(11):6256-62. PubMed ID: 11714788
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
13. Alpha1/alpha2 domains of H-2D(d), but not H-2L(d), induce "missing self" reactivity in vivo--no effect of H-2L(d) on protection against NK cells expressing the inhibitory receptor Ly49G2.
Johansson MH; Höglund E; Nakamura MC; Ryan JC; Höglund P
Eur J Immunol; 1998 Dec; 28(12):4198-206. PubMed ID: 9862356
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target.
Höglund P; Glas R; Ohlén C; Ljunggren HG; Kärre K
J Exp Med; 1991 Aug; 174(2):327-34. PubMed ID: 1856626
[TBL] [Abstract][Full Text] [Related]
16. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
Basiri H; Kiura K; DeNardin EG; Nakamura I
J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
[TBL] [Abstract][Full Text] [Related]
17. NK sensitivity, H-2 expression and metastatic potential: analysis of H-2Dk gene transfected fibrosarcoma cells.
Gopas J; Rager-Zisman B; Har-Vardi I; Hammerling GJ; Bar-Eli M; Segal S
J Immunogenet; 1989; 16(4-5):305-13. PubMed ID: 2639905
[TBL] [Abstract][Full Text] [Related]
18. The NK2.1 receptor is encoded by Ly-49C and its expression is regulated by MHC class I alleles.
Gosselin P; Lusignan Y; Brennan J; Takei F; Lemieux S
Int Immunol; 1997 Apr; 9(4):533-40. PubMed ID: 9138013
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T cell response to minor histocompatibility antigens: apparent lack of H-2 restriction in killers stimulated by membrane fragments.
Pilarski LM; Vergidis D
J Exp Med; 1982 Jul; 156(1):217-29. PubMed ID: 6177821
[TBL] [Abstract][Full Text] [Related]
20. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand.
Matsumoto N; Mitsuki M; Tajima K; Yokoyama WM; Yamamoto K
J Exp Med; 2001 Jan; 193(2):147-58. PubMed ID: 11148219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
